Shanti Overseas Fair Value
Shanti Overseas (SHANTI) average fair value is ₹10.23 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹7.42 (+37.94%), fair value range ₹4.01–₹15.11. For live price and a broader fundamental view, visit SHANTI company profile.
Fair Value Analysis Export
SHANTI Fair Value vs Current Price — Valuation Summary
SHANTI average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Explore Shanti Overseas intrinsic price to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
SHANTI Fair Value Analysis — Data Sources & Coverage
Shanti Overseas financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine Shanti Overseas quarterly earnings for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
SHANTI vs FMCG Sector Peers — P/E, P/B & Market Cap
Shanti Overseas P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sarda Proteins | SRDAPRT | -223.5 | 0.85 | ₹76 |
| Swasth Foodtech | SWASTH | 3.94 | 0.42 | ₹10 |
| Shreeji Global FMCG | SHETHJI | - | 2.41 | ₹280 |
| Nath Bio-Genes | NATHBIOGEN | 6.27 | 0.42 | ₹291 |
| Evexia Lifecar | EVEXIA | 59.0 | 0.21 | ₹115 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.